Methylation regulates HEY1 expression in glioblastoma

Glioblastoma (GBM) remains one of the most lethal and difficult-to-treat cancers of the central nervous system. The poor prognosis in GBM patients is due in part to its resistance to available treatments, which calls for identifying novel molecular therapeutic targets. In this study, we identified a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsung, Andrew J., Guda, Maheedhara R., Asuthkar, Swapna, Labak, Collin M., Purvis, Ian J., Lu, Yining, Jain, Neha, Bach, Sarah E., Prasad, Durbaka V.R., Velpula, Kiran K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546488/
https://www.ncbi.nlm.nih.gov/pubmed/28574840
http://dx.doi.org/10.18632/oncotarget.17897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546488/
https://www.ncbi.nlm.nih.gov/pubmed/28574840
http://dx.doi.org/10.18632/oncotarget.17897

Ejemplares similares